The IBD Center at Columbia has enrolled the first patient in a nationwide study using the established technique of sacral nerve stimulation (SNS) in a new way, for the treatment of Crohn’s Disease and ulcerative colitis.
Interventional IBD is a relatively new and evolving specialty that uses endoscopic therapies in place of traditional surgical techniques. We sat down with Dr. Bo Shen, founder of the specialty and director of the IBD Center at Columbia, to learn more.
Treating generations of families with rare hereditary colorectal cancers requires much of a different approach, one that includes caring for children. Dr. James Church discusses leading with compassion, empathy, and understanding before all else and tailoring treatments to individuals and their families.
Nadiuska Terrero thought her biggest medical hurdle was behind her after a kidney transplant in 2010. A decade later, in the midst of the COVID19 pandemic, she again found herself facing an uphill challenge – stage I colon cancer.
At the end of October, the U.S. Preventive Services Task Force updated their colon cancer screening guidelines to lower the age at which people should begin screening from age 50 to 45—a critical change that reflects a climbing trend of higher rates of colon and rectal cancer in younger people.
Colorectal cancer is one of the most common cancers in the United States, and the American Cancer Society estimates that almost 150,000 new cases of colon and rectal cancer will be diagnosed in 2020. Despite its growing prevalence, many people remain unaware of ways to monitor their risk.